BREAKING: Federal judge in Washington orders feds to keep abortion pill access
The dueling decisions threw into question access to the nation’s most common method of abortion, one that scientists have approved for use for decades.
U.S. District Judge Matthew J. Kacsmaryk, a Trump administration appointee in Amarillo, Texas, signed an injunctio n directing the Food and Drug Administration to stay mifepristone’s approval while a lawsuit challenging the safety and approval of the drug continues. That ruling came in a lawsuit brought by the conservative group Alliance Defending Freedom.
In Washington state, Spokane-based Judge Thomas O. Rice, an Obama administration appointee, partially granted a request from 17 states and the District of Columbia. While the states sued in an effort to expand access to the pill, Rice did not go that far - instead, he blocked the FDA from making any changes to the drug’s access in the states that sued.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Federal funding sought to eradicate destructive green crab in WashingtonThe European green crab can consume shellfish and other native marine life and destroy critical habitats.
Read more »
‘Praise This’ Is Now Streaming on Peacock: Here’s How You Can Watch Chlöe Bailey in the Musical FilmThe movie, starring Chlöe Bailey and Anjelika Washington, debuted Friday (April 7) on Peacock.
Read more »
The Nation's First Anti-Drag Law Was Temporarily Blocked By a Federal JudgeThe court sided with the plaintiff, saying the law unfairly targets drag performers.
Read more »
Federal judge halts FDA approval of abortion pill mifepristoneU.S. District Judge Matthew Kacsmaryk was appointed by former President Donald Trump.
Read more »
Federal judge rules to freeze use of abortion pill nationwideA federal judge in Texas moved to force the Food and Drug Administration to pull its approval of a drug widely used in medication abortion, throwing its availability into doubt.
Read more »